Thus, the block of SGLT2 pathways could interfere with different and multiple pathways via best glycemic control and significant reduction of inflammation and endothelial dysfunction in high risk patients, as those affected by T2DM and multi-vessel coronary stenosis. Here, SLC5A2 is linked to endothelial dysfunction.